New User:

Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 10, 2014
08:17 EDTMSTXMast Therapeutics agrees to acquire Aires Pharmaceuticals
Mast Therapeutics announced that it has entered into a definitive agreement to acquire Aires Pharmaceuticals, a clinical stage pharmaceutical company developing therapies to treat pulmonary vascular disorders such as pulmonary arterial hypertension and pulmonary hypertension due to heart failure. Aires' lead product, AIR001, is an intermittently nebulized formulation of nitrite and has orphan drug status with the FDA and the EMA for the treatment of pulmonary arterial hypertension. Under the terms of the all-stock transaction, Aires would become a wholly-owned subsidiary of Mast Therapeutics. The acquisition is expected to close in February 2014, subject to customary closing conditions.
News For MSTX From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
October 7, 2015
08:53 EDTMSTXMast Therapeutics to hold investor and analyst day
Investor and Analyst Day to be held in New York on October 7 at 1 pm. Webcast Link
October 5, 2015
20:26 EDTMSTXMast Therapeutics management to meet with Canaccord
Subscribe for More Information
September 30, 2015
08:09 EDTMSTXMast Therapeutics ammends loan and security agreement with Hercules Technology
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.
I agree to the disclaimer & terms of use